City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

The findings of this cohort study suggest that the incidence of pancreatic adenocarcinoma has increased among all age groups, whereas that of colorectal adenocarcinoma has increased among younger age ...

Journal of the National Comprehensive Cancer Network found significant disparities based on race, socioeconomic status, and ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...

Pancreatic cancer remains one of the most deadly malignancies, with nearly 52,000 deaths expected this year.  With limited therapeutic advances made i | Cancer ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment ...

The following is a summary of "Quality of life and toxicity in patients with pancreatic ductal adenocarcinoma treated with ...

The use of ablative radiation therapy (A-RT) led to promising overall survival and effective local tumor control in patients with technically resectable pancreatic ductal adenocarcinoma (PDAC) who ...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

The study found that patients who did receive appropriate systemic and/or palliative care were more likely to survive longer ...

New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with ...